PROPOLIS LOADED POLYVINYL ALCOHOL ATTENUATES CCL4 INDUCED HEPATIC FIBROSIS VIA MODULATION OF LET-7B/TGF-Β/SMAD SIGNALING PATHWAY
Keywords:gene expression, hepatic fibrosis, nanoparticles, nephropathy, propolis, CCl4
Chronic liver disorders are a serious global health issue due to their widespread incidence. Nephropathy described the deterioration of kidney function. Safe drug delivery by nanoparticles is a rapidly developing field with promising applications in the treatment of a wide variety of diseases. The current study aimed to evaluate the use of propolis nanoparticles for managing carbon tetrachloride (CCl4)-induced hepato-nephropathy on rats. Seventy adult males Spargue Dawley rats were allocated into 7 equal groups 10 rats of each. Control, CCl4, CCl4 +Silymarin, CCl4 + propolis, CCl4+Nanopropolis, CCl4 +Silymarin +Propolis, CCl4 +Silymarin +Nanopropolis. Hepato- nephropathy was induced with oral administration of CCl4 dissolved in olive oil at dose of (1gm/kg) for 4 weeks. Silymarin, propolis and nanopropolis were orally administrated at a dose of (200mg /kg), (100 mg/kg) and (30 mg /kg) respectively for 4 weeks post hepato-nephropathy onset. Biochemical, molecular analysis, histological assessment of liver and kidney and serum oxidative stress were done. CCl4 caused a marked deterioration in biochemical, oxidative stress markers (MDA, TAC, CAT), serum TNF-α, IgM, molecular markers (SMAD-2, SMAD-3, SMAD-7, MMP-9, Desmin, TGF-β1, and let-7b), and the histopathological pictures of both liver and kidney. The above-mentioned parameters were restored with administration of silymarim + Nano-propolis, silymarin + propolis, silymarin, Nano-propolis, and propolis in order. Based on the previous findings we could speculated that combined therapy of nano-propolis and silymarin could be implicated in managing hepato-nepheropathy since it improves both liver and kideny function by targeting let-7b/TGF-β/Smad Pathway.
● 1. Wang S, Friedman SL. Hepatic fibrosis: a convergent response to liver injury that is reversible. J Hepatol 2020; 73: 210–1. https://doi.org/10.1186/s12951-022-01356-2
● 2. Cai X, Wang J, Wang J, et al. Intercellular crosstalk of hepatic stellate cells in hepatic fibrosis: New insights into therapy. Pharmacol Res 2020; 155: 104720. https://doi.org/10.1016/j.phrs.2020.104720
● 3. De Muro P, Faedda R, Fresu P, et al. Urinary trans-forming growth factor-β1 in various types of nephropathy. Pharmacol Res 2004; 49: 293–8.
● 4. Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: From chemical–physical applications to nanomedicine. Mol 2019; 25: 112. https://doi.org/10.3390/molecules25010112
● 5. Mohseni R, Karimi J, Tavilani H, Khodadadi I, Hashemnia M. Carvacrol ameliorates the progression of hepatic fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats. Immunopharmacol Immunotoxicol 2019; 41: 163–71. https://doi.org/10.1080/08923973.2019.1566926
● 6. Bhargava P, Mahanta D, Kaul A, et al. Experimental Evidence for Therapeutic Potentials of Propolis. Nutrients 2021; 13: 2528. https://doi.org/10.3390/nu13082528
● 7. Santos LM, Fonseca MS, Sokolonski AR, et al. Prop-olis: types, composition, biological activities, and veterinary product patent prospecting. J Sci Food Agric 2020; 100: 1369-82. https://doi.org/10.1002/jsfa.10024
● 8. Tatli Seven P, Seven I, Karakus S, et al. Turkish prop-olis and its nano form can ameliorate the side effects of cisplatin, which is a widely used drug in the treatment of cancer. Plants 2020; 9: 1075. https://doi.org/10.3390/plants9091075
● 9. Soleimani V, Delghandi PS, Moallem SA, Karimi G. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytother Res 2019; 33: 1627-38. https://doi.org/10.1002/ptr.6361
● 10. Izzularab BM, Megeed, M, Yehia M. Propolis na-noparticles modulate the inflammatory and apoptotic pathways in carbon tetrachloride‐induced hepatic fibrosis and nephropathy in rats. Environ Toxicol 2021; 36: 55–66. https://doi.org/10.1002/tox.23010
● 11. Wang L, Huang QH, Li YX, et al. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Mol Med Rep 2018a; 17: 789–800. https://doi.org/10.3892/mmr.2017.7958
● 12. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 157; 28: 56–63. https://doi.org/10.1093/ajcp/28.1.56
● 13. Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK. Nanotechnology based drug delivery sys-tem: Current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol 2021; 63: 102487. https://doi.org/10.1016/j.jddst.2021.102487
● 14. El-Mahalaway AM, Selim AA, Mahboub FAR. The potential protective effect of propolis on experimentally induced hepatitis in adult male albino rats. Histological and immunohistochemical study. J Histol Histopathol 2015; 2: 14. https://doi.org/10.7243/2055-091X-2-14
● 15. Nakamura T, Ohta Y, Ohashi K, et al. Protective Ef-fect of Brazilian Propolis against Liver Damage with Cho-lestasis in Rats Treated with-Naphthylisothiocyanate. Evid-based Complement Altern Med 2013; 2013. https://doi.org/10.1155/2013/302720
● 16. de Melo MR, Junior AC, Oliveira KP, et al. Influence of Brazilian red propolis polymeric nanoparticles in haema-tology, renal, and hepatic evaluations in dogs. Res Soc Dev 2020; 9: e70391110531. https://doi.org/10.33448/rsd-v9i11.10531
● 17. AbdelMageed AD, Shaheen AA, Zahem R.M, Gad, NS. Biochemical and histopathological effect of propolis and nanopropolis supplementation on alleviating dietary Microcystis aeruginosa toxicity on Nile tilapia, Oreochromis niloticus. BVMJ 2019; 36: 150–60. https://doi.org/10.21608/BVMJ.2019.14704.1045
● 18. Abdo JA, Alsharif FM, Salah N, Elkhawaga OA. Cy-totoxic Effect of Propolis Nanoparticles on Ehrlich Ascites Carcinoma Bearing Mice. ANP 2019; 8: 55–70. https://doi.org/10.4236/anp.2019.84005
● 19. Kismet K, Ozcan C, Kuru S, et al. Does propolis have any effect on non-alcoholic fatty liver disease?. Biomed Pharmacother 2017; 90: 863–71. https://doi.org/10.1016/j.biopha.2017.04.062
● 20. Nna VU, Bakar ABA, Mohamed M. Malaysian propolis, metformin and their combination, exert hepato-protective effect in streptozotocin-induced diabetic rats. Life Sci 2018; 211: 40–50. https://doi.org/10.1016/j.lfs.2018.09.018
● 21. Long T, Wang L, Yang Y, et al. Protective effects of trans-2, 3, 5, 4′-tetrahydroxystilbene 2-O-β-D-glucopyranoside on hepatic fibrosis and renal injury induced by CCl 4 via down-regulating p-ERK1/2 and p-Smad1/2. Food Funct 2019; 10: 5115–23. https://doi.org/10.1039/C9FO01010F
● 22. Devaraj E, Roy A, Royapuram Veeraragavan, G, et al. β-Sitosterol attenuates carbon tetrachloride–induced oxidative stress and chronic liver injury in rats. Naunyn-Schmiedeb Arch Pharmacol 2020; 393: 1067–75. ttps://doi.org/10.1007/s00210-020-01810-8
● 23. Lee H, Han S, Kwon CS, Lee D. Biogenesis and regulation of the let-7 miRNAs and their functional implica-tions. Protein & cell 2016; 7: 100–13. https://doi.org/10.1007/s13238-015-0212-y
● 24. Hui L, Zheng F, Bo Y, et al. MicroRNA let-7b in-hibits cell proliferation via upregulation of p21 in hepatocel-lular carcinoma. Cell & Biosci 2020; 10: 1–2. https://doi.org/10.1186/s13578-020-00443-x
● 25. Chang JF, Hsieh CY, Lu KC, et al. Therapeutic tar-geting of aristolochic acid induced uremic toxin retention, SMAD 2/3 and JNK/ERK pathways in tubulointerstitial fibrosis: Nephroprotective role of propolis in chronic kid-ney disease. Toxins 2020; 12: 364. https://doi.org/10.3390/toxins12060364
● 26. Chen Y, Chen L, Yang T. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway. Life Sci 2021; 271: 119197. https://doi.org/10.1016/j.lfs.2021.119197
● 27. da Costa MF, Libório AB, Teles F, et al. Red propo-lis ameliorates ischemic-reperfusion acute kidney injury. Phytomedicine 2015; 22: 787–95, 2015. https://doi.org/10.1016/j.phymed.2015.03.017
● 28. Bhadauria M. Propolis prevents hepatorenal injury induced by chronic exposure to carbon tetrachloride. Evid-based Complement Altern Med 2012; 2012. https://doi.org/10.1155/2012/235358
● 29. Sameni HR, Ramhormozi P, Bandegi AR, Taherian AA, Mirmohammadkhani M, Safari M. Effects of ethanol extract of propolis on histopathological changes and anti‐oxidant defense of kidney in a rat model for type 1 diabetes mellitus. J Diabetes Investig 2016; 7: 506–13. https://doi.org/10.1111/jdi.12459
● 30. El-Haskoury R, Al-Waili N, Kamoun Z, Makni M, Al-Waili H, Lyoussi B. Antioxidant activity and protective effect of carob honey in CCl4-induced kidney and liver injury. Arch Med Res 2018; 49: 306–13. https://doi.org/10.1016/j.arcmed.2018.09.011
● 31. Yoshioka H, Usuda H, Fukuishi N, Nonogaki T, Onosaka S. Carbon tetrachloride-induced nephrotoxicity in mice is prevented by pretreatment with zinc sulfate. Biol Pharm Bull 2016; 39: 1042–6. https://doi.org/10.1248/bpb.b16-00078
● 32. Wang R, Wang J, Song F, Li S, Yuan Y. Tanshinol ameliorates CCl4-induced hepatic fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway. Drug Des Devel Ther 2018b; 12: 1281. https://doi.org/10.2147/DDDT.S159546
● 33. El-Bahr SM, El-Deeb WM, Hashem AS. Biochemi-cal and Molecular Investigation of Antioxidant Enzymes in Liver Tissue of Rats Intoxicated with Carbon Tetrachloride and Treated with Aqueous Extract of Fenugreek (Trigonella foenum-graecum L.)
● 34. Al-Sultan SI, El-Bahr SM. Effect of aqueous extract of fenugreek (Trigonella foenum-graecum L.) on selected biochemical and oxidative stress biomarkers in rats intoxi-cated with carbon tetrachloride. IJP 2015; 11: 43–9.
● 35. El-Bahr SM. Camel milk regulates gene expression and activities of hepatic antioxidant enzymes in rats intoxi-cated with carbon tetrachloride. Asian J Biochem 2014; 9: 30–40.
● 36. Althnaian T, Albokhadaim I, El-Bahr S.M. Bio-chemical and histopathological study in rats intoxicated with carbontetrachloride and treated with camel milk. SpringerPlus 2013: 2: 1–7.
How to Cite
Copyright (c) 2023 SLOVENIAN VETERINARY RESEARCH
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.